CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulation of SEBI Listing Regulations, 2015, we would like to inform you that registrar and share transfer agent of company M/S. KFin Technologies limited has received intimation for loss of shares certificate and request for issuance of duplicate shares certificates Cipla launches drone delivery of critical medicines in HP
The use of drones will support on-time delivery of the company's medicines to chemists and clinics in remote areas, while minimizing risks including temperature-linked issuesaffecting cold chain products Cipla's InvaGen site gets 5 USFDA observations
InvaGen Pharmaceuticals is a wholly-owned subsidiary of Cipla, and the latter's shares were down over 2 percent on BSE, Thursday, at 1,213.25 (at 13.10 hrs) CIPLA LTD. - 500087 - USFDA Inspection At Invagen Manufacturing Facility In Central Islip, Long Island, NY, USA
Updates on USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA is enclosed.
Cipla share price Today Live Updates : Cipla's stock rises on positive trading day
Cipla stock price went up today, 20 Sep 2023, by 0.32 %. The stock closed at 1240.45 per share. The stock is currently trading at 1244.45 per share. Investors should monitor Cipla stock price closely in the coming days and weeks to see how it reacts to the news. CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) and other applicable regulations SEBI (Listing Obligations and Disclosures Requirement) Regulation 2015 we would like to inform you that registrar and share transfer agent of company M/S KFin Technologies Limited has received intimation for loss of share certificate and request for issuance of duplicate share certificates. CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulation of SEBI (listing Obligation and disclosure requirement) Regulation 2015, we would like to inform you that the registrar and share transfer agent of company M/S. KFin Technologies Limited has received intimation for loss of shares certificate and request for issuance of duplicate shares certificates. CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operation and administrative Committee of the Company on 11th September, 2023 has allotted 7,188 fully paid-up equity shares pursuant to exercise of ESOP / ESAR. Consequently, the issued, subscribed and paid up share capital of the company increased to INR 1,61,46,34,956 comprising of 80,73,17,478 equity shares.
Competition intensifies for Cipla: Lucrative opportunity or challenge?
US-based private equity firm Bain Capital is exploring a joint bid with Dr. Reddy's Laboratories for the promoter stake Cipla expands healthcare presence with acquisition of Actor Pharma
Shares were up 1.34 per cent on the acquisition